The company specializes in using CpG oligonucleotides to discover and develop immunotherapies that increase the efficacy of existing treatments and provide new options for cancer patients. Founded in 2015 and based in Cambridge, Massachusetts, Checkmate Pharmaceuticals is focused on activating innate immunity to treat cancer.